Skip to main content

digital therapeutics

By HIMSS TV | 07:00 am | June 12, 2024
Andy Molnar, CEO of the Digital Therapeutics Alliance, and Scott Stuewe, president and CEO of DirectTrust, discuss their partnership to show digital therapeutics' value and accreditation in healthcare for payors considering DTx coverage.  
HIMSS24
By HIMSS TV | 06:13 pm | May 01, 2024
Dr. Guido Giunti, Trinity College Dublin's digital therapeutics lead, relays how the institution created a digital therapeutic for multiple sclerosis patients to fight fatigue and his journey to becoming a HIMSS Changemaker award recipient.  
HIMSS23
By HIMSS TV | 07:00 am | May 23, 2023
Digital therapeutics improve access to care, but face reimbursement challenges. Jessica Hauflaire, COO of the Digital Therapeutics Alliance, describes the DTA's work with CMS and policymakers to gain support for this new care model.
By HIMSS TV | 04:09 pm | October 13, 2021
Armin Scheuer, VP of Business Development International at HIMSS, says Germany is prescribing apps to patients within their normal care setting, in the form of DiGAs, and France has decided to replicate the system.
By HIMSS TV | 01:57 pm | July 29, 2021
There needs to be collaboration between the healthcare professional and the patient as opposed to the "carwash model" of healthcare, says Medisafe CMO Dr. Danny Sands.
By HIMSS TV | 03:34 pm | October 08, 2020
Liz Ashall-Payne, founder and CEO of ORCHA, says COVID-19 has accelerated the adoption of telehealth, but digital therapeutics, diagnostics and remote patient monitoring will play a more significant role moving forward.
By HIMSS TV | 08:03 am | November 25, 2019
Happify Health's Chris Wasden discusses getting at the root cause rather than just treating symptoms by addressing chronic conditions from a behavior-change perspective.
By Dave Muoio | 04:18 pm | October 07, 2019
The independent investigation suggests that wirelessly observed therapies using Proteus' system could be considered equivalent to in-person medication adherence programs, but much better received by patients taking oral medications.
By Laura Lovett | 01:16 pm | January 03, 2019
Otsuka intends to invest more than $300 million in an FDA-cleared software app that will apply cognitive therapy principals either with or without prescription drugs. 
By Dave Muoio | 05:23 pm | October 15, 2018
As the Abilify MyCite platform nears a full rollout, the companies said they are looking forward to employing the technology toward additional mental health therapies.

MobiHealthNews